TippingPoint Biosciences Raises $4.5M Seed Round Led by SOSV to Develop Chromatin-Targeting Cancer Drug Platform
TippingPoint Biosciences, a San Francisco-based biotech startup developing next-generation therapeutics for cancer and other diseases driven by chromatin dysfunction, has raised $4.5 million in seed…